Nautilus Biotechnology, Inc.
NAUT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $107 | $91 | $108 | $211 |
| - Cash | $24 | $34 | $33 | $28 |
| + Debt | $27 | $28 | $29 | $30 |
| Enterprise Value | $110 | $85 | $104 | $214 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2 | -$2 | -$2 | -$6 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$13 | -$15 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$15 | -$17 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.11 | -0.12 | -0.13 | -0.14 |
| % Growth | 8.3% | 7.7% | 7.1% | – |
| Operating Cash Flow | -$11 | -$13 | -$14 | -$14 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$11 | -$14 | -$14 | -$15 |